Publications

2014
Sundstrom J, Arima H, Woodward M, et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591-8.
Arima H, Anderson CS, Omae T, et al. Degree of blood pressure reduction and recurrent stroke: the PROGRESS trial. Journal of Neurology, Neurosurgery, and Psychiatry. 2014;pii: jnnp-2014-307856.
T C, Woodward M, Roth G, et al. Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Medicine. 2014;11:e1001699.
Yan LL, Fang W, Delong E, et al. Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial. BMC Public Health. 2014;14:345.
Rahimi K, Bennett D, Conrad N, et al. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Failure. 2014;2:440-6.
Brugts JJ, Arima H, Remme W, et al. The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. International Journal of Cardiology. 2014;pii: S0167-5273(14)01318-7.
2013
Praveen D, Patel A, McMahon S, et al. A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial. Implementation Science. 2013;8:137.
Rist PM, J C, Arima H, et al. Baseline cognitive function, recurrent stroke, and risk of dementia in stroke patients. Stroke. 2013;44:1790-95.
Ninomiya T, Perkovic V, Turnbull F, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680. doi:10.1136/bmj.f5680.
Ninomiya T, Perkovic V, Turnbull F, et al. Blood pressure-lowering and major cardiovascular events in people with and without chronic kidney disease: a meta-analysis of randomised controlled trials. British Medical Journal. 2013;347.
Yan LL, Fang W, Delong E, et al. China Rural Health Initiative – Primary care provider study: A large cluster-randomized controlled trial of high cardiovascular risk management in rural China. In: American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Science: Special Reports. American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Science: Special Reports. Dallas, Texas, USA; 2013.
Li N, Yan LL, Niu W, et al. China Rural Health Initiative – Sodium Reduction Study: the effect of a community-based sodium reduction program on 24hr urinary sodium and blood pressure in rural China. In: American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Trials. American Heart Association Scientific Sessions 2013 - Late Breaking Clinical Trials. Dallas, Texas, USA; 2013.
Hata J, Arima H, Zoungas S, et al. Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial. PLOS ONE. 2013;8.
Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patient with type 2 diabetes: the ADVANCE trial. Circulation. 2013;128:1325-34.
Perkovic V, Heerspink HL, J C, et al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney International. 2013;83:517-23.
2012
McAlister FA, Marzona I, Dagenais GR, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials. European Heart Journal. 2012;33:505-14.
Zoungas S, J C, Ninomiya T, et al. Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia. 2012;55:636-643.
Arima H, Anderson CA, Omae T, et al. Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial. Stroke. 2012;43:1675-7.
LV J, Neal B, Ehteshami P, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis. PLoS Medicine. 2012;9:e1001293.
Hata J, Arima H, Rothwell PM, et al. Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial. In: 21st European Stroke Conference. 21st European Stroke Conference. Lisbon, Portugal; 2012.
McMahon S. “Frugal” healthcare innovation – a global research priority. In: The Academy of Medical Sciences. New Fellows admission day. The Academy of Medical Sciences. New Fellows admission day. London, United Kingdom; 2012.
McMahon S. Frugal innovation - The future of cardiovascular medicine. In: Lewis A. Conner Memorial Lecture, Scientific Sessions, American Heart Association. Lewis A. Conner Memorial Lecture, Scientific Sessions, American Heart Association. Los Angeles, USA; 2012.
Bennett DA, Eliasz TK, Forbes A, et al. Study protocol: systematic review of the burden of heart failure in low- and middle-income countries. Cochrane Database of Systematic Reviews. 2012;1:59.
Joshi R, Chow C, Raju PK, et al. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. Journal of the American College of Cardiology. 2012;59:1188-96.
Peiris D, Usherwood T, Panaretto K, et al. The Treatment of cardiovascular Risk in Primary care using Electronic Decision supOrt (TORPEDO) study-intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention i. BMJ Open. 2012;2.

Pages